Nektar Therapeutics | NKTR - Capitalización De Mercado

Precio De Mercado
77.50
Cambio Diario
-0.35 -0.45%
Mensual
5.69%
Anual
736.44%
Q2 Expectativa
75.38




Capitalización De Mercado Cambio Fecha
Agios Pharmaceuticals USD 1.59B 745M 2025-12
ALKERMES USD 4.62B 333M 2025-12
Alterity Therapeutics Limited AUD 30M 26M 2026-04
Amgen USD 176.25B 24.32B 2025-12
Baxter International USD 9.82B 1.87B 2025-12
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Biogen USD 25.82B 5.28B 2025-12
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Cara Therapeutics USD 366M 338M 2025-09
Cipla INR 1.22T 6.47B 2025-12
Dr.Reddys Laboratories INR 1.06T 39.78B 2025-12
Eisai JPY 1.31T 140.95B 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Esperion Therapeutics USD 885M 351M 2025-12
Exelixis USD 11.75B 959M 2025-12
Gilead Sciences USD 152.28B 14.55B 2025-12
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
Halozyme Therapeutics USD 7.91B 664M 2025-12
Incyte USD 19.39B 2.83B 2025-12
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
Karyopharm Therapeutics USD 652M 517M 2026-04
MacroGenics USD 102M 4M 2025-12
Merck USD 261.26B 51.62B 2025-12
Nektar Therapeutics USD 14.34B 13.48B 2026-04
Neurocrine Biosciences USD 14.14B 218M 2025-12
Novartis USD 292.21B 26.55B 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Takeda JPY 7.64T 774.9B 2025-12
Teva Pharmaceutical Industries USD 36.42B 14.06B 2025-12
Xencor USD 1.09B 256M 2025-12